Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Drucker

Showing results (341-350 of 549) with videos related to

Pageof 55
Sort By:
The International Journal of Pediatric Nephrology|March 1, 1982
Vaccine against hepatitis B in children: prevention of hepatitis in a pediatric hemodialysis unitH Nivet, J Drucker, F Dubois, et al.
La Nouvelle Presse Medicale|April 19, 1980
[Bartter's syndrome: seven cases in siblings. Hypothesis of mild forms (author's transl)]H Nivet, J C Rolland, Y Lebranchu, et al.
Archives Francaises De Pediatrie|November 1, 1982
[Fatal liver disorder during treatment with sodium valproate and carbamazepine]J C Rolland, E Autret, J Drucker, et al.
Diabetes|January 24, 2003
Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomyDiva D De León, Shaoping Deng, Reza Madani, et al.
Journal of Lipid Research|August 21, 2012
Lipid-mediated release of GLP-1 by mouse taste buds from circumvallate papillae: putative involvement of GPR120 and impact on taste sensitivityCéline Martin, Patricia Passilly-Degrace, Michaël Chevrot, et al.
Endocrinology|September 20, 2008
Acute dipeptidyl peptidase-4 inhibition rapidly enhances insulin-mediated suppression of endogenous glucose production in miceHélène Duez, Angela C Smith, C Xiao, et al.
Gastroenterology|June 16, 2009
ErbB signaling is required for the proliferative actions of GLP-2 in the murine gutBernardo Yusta, Dianne Holland, Jacqueline A Koehler, et al.
American Journal of Physiology. Renal Physiology|July 27, 2012
Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic miceTimo Rieg, Maria Gerasimova, Fiona Murray, et al.
Canadian Journal of Diabetes|November 1, 2024
Glucagon-like Peptide-1 Receptor Agonist Use in Hospital: A Multicentre Observational StudyPrachi Ray, Jason A Moggridge, Alanna Weisman, et al.
Endocrine Reviews|December 15, 2020
Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor ActivationBrent A McLean, Chi Kin Wong, Jonathan E Campbell, et al.
Pageof 55

Showing results (341-350 of 549) with videos related to

Sort By:
Pageof 55
The International Journal of Pediatric Nephrology|March 1, 1982
Vaccine against hepatitis B in children: prevention of hepatitis in a pediatric hemodialysis unitH Nivet, J Drucker, F Dubois, et al.
La Nouvelle Presse Medicale|April 19, 1980
[Bartter's syndrome: seven cases in siblings. Hypothesis of mild forms (author's transl)]H Nivet, J C Rolland, Y Lebranchu, et al.
Archives Francaises De Pediatrie|November 1, 1982
[Fatal liver disorder during treatment with sodium valproate and carbamazepine]J C Rolland, E Autret, J Drucker, et al.
Diabetes|January 24, 2003
Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomyDiva D De León, Shaoping Deng, Reza Madani, et al.
Journal of Lipid Research|August 21, 2012
Lipid-mediated release of GLP-1 by mouse taste buds from circumvallate papillae: putative involvement of GPR120 and impact on taste sensitivityCéline Martin, Patricia Passilly-Degrace, Michaël Chevrot, et al.
Endocrinology|September 20, 2008
Acute dipeptidyl peptidase-4 inhibition rapidly enhances insulin-mediated suppression of endogenous glucose production in miceHélène Duez, Angela C Smith, C Xiao, et al.
Gastroenterology|June 16, 2009
ErbB signaling is required for the proliferative actions of GLP-2 in the murine gutBernardo Yusta, Dianne Holland, Jacqueline A Koehler, et al.
American Journal of Physiology. Renal Physiology|July 27, 2012
Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic miceTimo Rieg, Maria Gerasimova, Fiona Murray, et al.
Canadian Journal of Diabetes|November 1, 2024
Glucagon-like Peptide-1 Receptor Agonist Use in Hospital: A Multicentre Observational StudyPrachi Ray, Jason A Moggridge, Alanna Weisman, et al.
Endocrine Reviews|December 15, 2020
Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor ActivationBrent A McLean, Chi Kin Wong, Jonathan E Campbell, et al.
Pageof 55